Announcement on the non-adjustment of the coupon rate of the "13 Peak 02" corporate bonds.
Release time:
2020-08-05
Stock Code: 600668 Stock Abbreviation: Jianfeng Group Announcement No.: Pro 2017-026
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement on No Adjustment of Interest Rate of "13 Peak 02
" Corporate BondThe Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assume individual and joint responsibility for the truthfulness, accuracy and completeness of its contents.
Important Content Note:
● Interest Rate Applicable Before Adjustment: 5.09%
● . Interest Rate Applicable After Adjustment; 5.09%
● . Starting date: 2017 11 September 20
According to the "Prospectus for Public Issuance of Corporate Bonds (Phase II) by Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as" Company "or" Issuer ") 2014 11 July 18 , the issuer has the right to decide whether to increase the coupon rate of the current bond at the end of the end of the term of the current bond. The annual coupon rate of the current bond for 3 years before the duration is 5.09% , and it will remain unchanged for 3 years before the duration of the bond. At the end of 3 of the duration of the current bond, the company will not adjust the coupon rate, I .e. the coupon rate will remain 5.09% , and will remain fixed for the subsequent duration of the current bond. The specific measures for the implementation of the resale of corporate bonds will be announced separately. In order to ensure the smooth progress of the issuer's interest rate increase option, the relevant matters are hereby announced as follows:
1. the adjustment of current bond interest rate
The annual coupon rate of current bond is
5.09%for the first
3years (2014 11 September 20 to 2017 11 May 19 ), fixed for the first 3 years of the bond's life; at the end of 3 of the current bond's life, the issuer opted not to raise the coupon rate, which was 5.09% , and it will remain unchanged in (2017 11 20 to 2019 11 19 ) after the current bond. The bonds bear interest on an annual basis at simple interest, without compound interest. 2. the relevant organization
1
of the current bond resale, issuer: Zhejiang Jianfeng Group Co., Ltd.domicile:
, No. 88
Wujiang East Road, Jinhua City, Zhejiang Province Legal Representative: Jiang XiaomengContact: Zhu Jianwei, Zhou Hengbin
Tel: 0579-82320582
, 82324699Fax: 0579-82320582
, 82324699
2, Lead Underwriter: Zheshang Securities Co., Ltd.
Legal Representative: Wu ChenggenResidence: No. 201
, Wuxing Road, Jianggan District, HangzhouContact: Hua Jia, Ma Yanxiao
Tel: 0571-87902082
, 87903124Fax: 0571-87903239
3
, Custodian: China Securities Depository and Clearing Corporation Limited Shanghai BranchAddress:
, 3rd Floor, China Insurance Building, 166
, Lujiazui East Road, Shanghai Contact: Xu YingTel: 021-68870114
Fax: 021-68875802 157
Postal Code: 200120is hereby announced.
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors2017
10
March
9
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31